Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down before the market opened on Monday . The stock had previously closed at $8.74, but opened at $8.08. Curaleaf shares last traded at $8.72, with a volume of 3,814 shares.

Analysts Set New Price Targets

Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat, Curaleaf presently has an average rating of “Strong Buy”.

Curaleaf Stock Performance

The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of -22.11 and a beta of 1.51. The stock has a 50 day simple moving average of $7.11 and a two-hundred day simple moving average of $7.67.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. As a group, analysts anticipate that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.